Ackermans & Van Haaren NV (EBR:ACKB)
Belgium · Delayed Price · Currency is EUR 257.20
-6.20 (-2.35%)
At close: Mar 20, 2026
Ackermans & Van Haaren NV Revenue
In the year 2025, Ackermans & Van Haaren NV had annual revenue of 5.96B EUR, down -1.35%. Ackermans & Van Haaren NV had revenue of 2.93B in the half year ending December 31, 2025, with 4.82% growth.
Revenue
5.96B
Revenue Growth
-1.35%
P/S Ratio
1.41
Revenue / Employee
239.12K
Employees
24,931
Market Cap
8.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.96B | -81.72M | -1.35% |
| Dec 31, 2024 | 6.04B | 821.78M | 15.74% |
| Dec 31, 2023 | 5.22B | 820.13M | 18.63% |
| Dec 31, 2022 | 4.40B | 104.05M | 2.42% |
| Dec 31, 2021 | 4.30B | 387.12M | 9.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Umicore | 19.37B |
| Viohalco | 7.23B |
| bpost NV/SA | 4.48B |
| DEME Group NV | 4.15B |
| NV Bekaert | 3.71B |
| Cenergy Holdings | 2.06B |
| Deceuninck NV | 772.70M |
| Floridienne | 719.54M |
Ackermans & Van Haaren NV News
- 22 days ago - Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%) - GlobeNewsWire
- 4 months ago - Ackermans & Van Haaren Says On Track To Record At Least 15% Annual Earnigns Growth - Nasdaq
- 4 months ago - Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed - GlobeNewsWire
- 6 months ago - Ackermans & van Haaren invests 22 million euros in VKC Nuts - GlobeNewsWire
- 7 months ago - Ackermans & van Haaren supports MRM Health's Series B financing round of 55 million euros - GlobeNewsWire
- 7 months ago - Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners - GlobeNewsWire
- 7 months ago - Ackermans & van Haaren: First-Half 2025 Results - GlobeNewsWire
- 10 months ago - Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a vast majority - GlobeNewsWire